SBFM Q2 2022 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q2 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$150,307+184.3% YoY

Gross Profit

$75,62450.3% margin

Operating Income

-$695,796-462.9% margin

Net Income

-$538,872-358.5% margin

EPS (Diluted)

$-60.00

QoQ Revenue Growth

+22.6%

Cash Flow

Operating Cash Flow

-$573,802

Free Cash Flow

-$573,802

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$42M

Total Liabilities

$104,684

Stockholders' Equity

$42M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$150,307	$52,874	+184.3%
Gross Profit	$75,624	$34,359	+120.1%
Operating Income	-$695,796	-$389,000	-78.9%
Net Income	-$538,872	-$3M	+81.3%